Litcius/Paper detail

Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis

Alessandro Loglio, Péter Ferenci, Sara Uceda Renteria, C Tham, Caroline Scholtès, Heidemarie Holzmann, Florian van Bömmel, Marta Borghi, Riccardo Perbellini, Alessandro Rimondi, Elisa Farina, Elena Trombetta, Maria Manunta, Laura Porretti, Daniele Prati, Ferruccio Ceriotti, Fabien Zoulim, Antonio Bertoletti, Pietro Lampertico

2021Journal of Hepatology66 citationsDOI

Topics & Concepts

MedicineCirrhosisHBsAgGastroenterologyInternal medicineAsymptomaticHepatitis D virusHepatitis DLiver functionHepatocellular carcinomaHBeAgHepatitis B virusImmunologyVirusHepatitis B Virus StudiesHepatitis C virus researchHepatitis Viruses Studies and Epidemiology
Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis | Litcius